A groundbreaking achievement has been reached in the fight against malaria. Novartis announced today that its revolutionary medication has received regulatory approval to address malaria in newborns and infants, signaling a major advancement in global health. This innovative drug will now be available to countries where malaria is most prevalent, … Read More